Наши
публикации
КАДАП
European Drug Report 2021: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug...
The EU Early Warning System on new psychoactive substances (NPS)
The EU Early Warning System, operated by the EMCDDA in close cooperation with Europol, plays a central role in supporting national- and EU-level preparedness and...
Action framework for developing and implementing health and social responses to drug problems
The action framework introduced here will help to clarify current thinking about the response process and the factors to take into account at each stage....
New psychoactive substances: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview...
EMCDDA initial report on the new psychoactive substance 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC)
3-MMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2012. Based on...
Risk assessment of new psychoactive substances (NPS)
Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to...
Prevention toolkit
The EMCDDA Prevention toolkit brings together useful tools and resources for anyone involved in shaping decisions, opinions and policies in Europe in the science-based prevention...
Spotlight on… Drug checking
Drug-checking services provide individuals who use drugs with information on the chemical content of their drugs as well as advice and, sometimes, counselling or brief...
